Investment Summary

NewSpring Capital Invests In Putney

On October 3, 2011, private equity firm NewSpring Capital invested in life science company Putney

Investment Highlights
  • This is NewSpring Capital’s 9th transaction in the Life Science sector.
  • This is NewSpring Capital’s 57th transaction in the United States.
  • This is NewSpring Capital’s 1st transaction in Maine.
Investment Fate
  • Putney was sold to a publicly-traded strategic buyer in 2016 for 200M USD.

Investment Summary

Date 2011-10-03
Target Putney
Sector Life Science
Investor(s) NewSpring Capital
Deal Type Venture

Target

Putney

Portland, Maine, United States
Putney, Inc. is a pharmaceutical company, providing high quality, cost-effective generic medicines for pets. Putney's reliable supply of affordable drug options empowers veterinarians, allowing them to provide the best possible medicine at the best possible price, and supports pet owners, helping them afford to comply with veterinary recommendations.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

NewSpring Capital

Radnor, Pennsylvania, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 3.5B USD
Size Large
Type Sector Agnostic
DESCRIPTION

NewSpring Capital is a private investment firm focused on growth companies in the Mid-Atlantic US. The Firm can provide both growth equity and junior capital to prospective companies. NewSpring's target investment size for both mezzanine and equity financing is $2 to $5 million, although for new ventures, the Firm can commit up to $10 million. Sectors of interest include specialty manufacturing, technology, business services, information technology, life science, healthcare services, and medical devices. NewSpring Capital was formed in 1999 and is based in Radnor, Pennsylvania with an additional office in Short Hills, New Jersey.


DEAL STATS #
Overall 58 of 201
Sector: Life Science M&A 9 of 12
Type: Venture M&A Deals 17 of 24
State: Maine M&A 1 of 1
Country: United States M&A 57 of 197
Year: 2011 M&A 7 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-07 Brandmuscle

Chicago, Illinois, United States

Brandmuscle is a local marketing software company that enables brands to own the local decision point by empowering their network of local distributors, dealers, franchisees and salespeople with everything they need to deliver brand-approved marketing tactics customized to local needs, tastes and other relevant differences that can affect the sale. Brandmuscle was founded in 2000 and based in Chicago, Illinois.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-10-13 Salveo Specialty Pharmacy

Saint Petersburg, Florida, United States

Salveo Specialty Pharmacy, Inc. is a specialty pharmacy organization serving patients and customers across the country. Salveo acquires, integrates and grows select specialty pharmacy organizations that share its philosophy of providing superior customer service and clinical patient care to the chronically ill population.

Buy -